首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
齿轮混合泵
摘要
申请公布号
TW045694
申请公布日期
1982.08.01
申请号
TW07025394
申请日期
1981.09.11
申请人
仓田道范
发明人
仓田道范
分类号
F04C2/18
主分类号
F04C2/18
代理机构
代理人
林敏生 台北巿南京东路二段一二五号七楼伟成第一大楼
主权项
一种齿轮混合泵,具备有:在其内部设有吸入室,第1混合室、混合推送室、第2混合室,及昇压室之泵壳匣。在各室内回转自如的,互相啮合的设置,吸入齿轮,第1混合齿轮,,驱动齿轮,第2混合齿轮,及昇压齿轮,将上述5个之齿轮回转于各规定方向而令依序经过吸入室,第1混合室、混合推送室,第2混合室及昇压室而移送,并实施液体之混合而构成为其特征者。
地址
日本三重县津巿大里洼田町8錂9–2
您可能感兴趣的专利
ENERGY-ACCUMULATION CONNECTION BETWEEN WALL PANELS
A process for realkalization of concrete using potassium carbonate
Secured sanitary catheter for administering liquids into cardiovascular system of animals during slaughter
Light induced cleavage of DNA with photosensitive texaphyrin
Laktonb¶rende absorberbare polymerer
Process for liquefying a natural gas stream containing at least one freezable component
Cigarette packet with integral matchbox in its base
Hand-held terminal for projecting internet related images on flat surface, receives data from keyboard, radio link, infra red link, etc.
Sustained release formulation comprising carbamazepine and methacrylic polymer wherein the size of the carbamazepine particles is from a mesh size from 30-200
Diagnostic methods and kits for specific for dopamine-beta-hydroxylase
A coagulation-deficient tissue factor (TF) compound [e.g. IgG-H6-N'-cys-tTF219] that is at least 100 times less active than the native form and its use against vascular tumour
A newspaper circulation system which selectively delivers different products to different customers
Use of 19-nor-vitamin D compounds for the prevention of hyperphosphatemia
Compositions for regulating heme-oxygenase and nitric oxide in mammals
Coffee machine with valve between brewing chamber and outlet having flow rate adjustable
Commodity consumption meter with interface for display driver and add on processing element
Photosensitizing compositions and articles for reducing the effects of inflammation
Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
Dimeric compounds such as N-(2-{7-[2-({3-[2-(acetylaminoethyl]-1-benzofuran-5-yl}oxy)ethoxy]-1-naphthyl}-ethyl)acetamide for the treatment of melatonin related disorders
3-Substituted 3,4,5,7-tetrahydropyrrolo[3',4':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and use as 5HT antagonists